scholarly journals Prevalence and Factors Associated with HIV and Hepatitis B and Hepatitis C Co Infection in Children Attended at the Hubert Koutoukou Maga National University Teaching Hospital (CNHU-HKM) of Cotonou

2017 ◽  
Vol 07 (03) ◽  
Author(s):  
Marcelline d Almeida ◽  
Lutecia Guidibi Zohoun ◽  
Didier Julien Adedemy ◽  
Honorat Francis Lalya ◽  
Hosmine Gbogbo ◽  
...  
Author(s):  
Chiekulie Kevin Diwe ◽  
Emmanuel Chidiebere Okwara ◽  
Oguamanam Okezie Enwere ◽  
Jerome Emeka Azike ◽  
Nathan Chibuzo Nwaimo

2019 ◽  
Vol 09 (02) ◽  
pp. 251-259
Author(s):  
Abdourahamane Diallo ◽  
Ibrahima Sory Baldé ◽  
Ibrahima Sory Diallo ◽  
Mamadou Hady Diallo ◽  
Mamadou Cellou Diallo ◽  
...  

2019 ◽  
Vol 24 (27) ◽  
Author(s):  
Nick Bundle ◽  
Sooria Balasegaram ◽  
Sarah Parry ◽  
Sadna Ullah ◽  
Ross J Harris ◽  
...  

Background Progress towards HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) elimination requires local prevalence estimates and linkage to care (LTC) of undiagnosed or disengaged cases. Aim We aimed to estimate seroprevalence, factors associated with positive blood-borne virus (BBV) serology and numbers needed to screen (NNS) to detect a new BBV diagnosis and achieve full LTC from emergency department (ED) BBV testing. Methods During a 9-month programme in an ED in east London, England, testing was offered to adult attendees having a full blood count (FBC). We estimated factors associated with positive BBV serology using logistic regression and NNS as the inverse of seroprevalence. Estimates were weighted to the age, sex and ethnicity of the FBC population. Results Of 6,211 FBC patients tested, 217 (3.5%) were positive for at least one BBV. Weighted BBV seroprevalence was 4.2% (95% confidence interval (CI): 3.6–4.9). Adjusted odds ratios (aOR) of positive BBV serology were elevated among patients that were: male (aOR: 2.7; 95% CI: 1.9–3.9), 40–59 years old (aOR: 1.9; 95% CI: 1.4–2.7), of Black British/Black other ethnicity (aOR: 1.8; 95% CI: 1.2–2.8) or had no fixed address (aOR: 2.9; 95% CI: 1.5–5.5). NNS to detect a new BBV diagnosis was 154 (95% CI: 103–233) and 135 (95% CI: 93–200) to achieve LTC. Conclusions The low NNS suggests routine BBV screening in EDs may be worthwhile. Those considering similar programmes should use our findings to inform their assessments of anticipated public health benefits.


2021 ◽  
Author(s):  
Supanat Thitipatarakorn ◽  
Tanat Chinbunchorn ◽  
Jitsupa Peelay ◽  
Pich Seekaew ◽  
Sorawit Amatavete ◽  
...  

Abstract Background Viral hepatitis is highly prevalent among people living with HIV (PLHIV) and can lead to chronic liver complications. Thailand started universal hepatitis B vaccination at birth in 1992. We explored prevalence rates of hepatitis B and C and associated factors among PLHIV from same-day antiretroviral therapy (SDART) service at the Thai Red Cross Anonymous Clinic, Bangkok, Thailand. Methods We collected baseline characteristics from PLHIV enrolled in the SDART service between July 2017 and November 2019. Multivariate logistic regression was carried out to determine factors associated with positive hepatitis B surface antigen (HBsAg) and hepatitis C antibody (anti-HCV). Results We included a total of 4,011 newly diagnosed PLHIV who had HBsAg or anti-HCV results at baseline. Included were 2,941 men who have sex with men (MSM; 73.3%), 851 general population (21.2%), 215 transgender women (TGW; 5.4%), and 4 transgender men (0.1%). Median age was 27 years. Overall seroprevalence of HBsAg and anti-HCV were 6.0% and 4.1%, respectively. Subgroup prevalence rates were 6.2% and 4.7% among MSM, 4.6% and 2.4% among general population, and 9.3% and 3.7% among TGW. Factors associated with HBsAg positivity were being MSM (adjusted odds ratio [aOR] 1.64, 95% confidence interval [CI] 1.13 to 2.40), being TGW (aOR 2.87, 95% CI 1.60 to 5.17), birth year before 1992 (aOR 2.32, 95% CI 1.69 to 3.16), CD4 count < 200 cells/mm3 (aOR 1.38, 95% CI 1.03, 1.86), and alanine aminotransferase ≥ 62.5 U/L (aOR 2.39, 95% CI 1.66 to 3.43). Factors associated with anti-HCV positivity were being MSM (aOR 2.11, 95% CI 1.26 to 3.55), age > 30 years (aOR 1.54, 95% CI 1.10 to 2.17), alanine aminotransferase ≥ 62.5 U/L (aOR 7.74, 95% CI 5.48 to 10.9), creatinine clearance < 60 ml/min (aOR 5.58, 95% CI 1.95 to 16.0), and having syphilis (aOR 1.95, 95% CI 1.36 to 2.78). Conclusions Around 5–10% of newly diagnosed PLHIV in Bangkok had hepatitis B infection after 25 years of universal vaccination. Anti-HCV positivity was found in 4–5% of PLHIV who were MSM and TGW. Every PLHIV should be routinely tested for hepatitis B and C and immediately linked to appropriate prevention and treatment interventions.


2019 ◽  
Author(s):  
Bereket Beyene Gebre

Abstract Abstract Objective: To assess the magnitude of alcohol use and factors among HIV/AIDS positive adults visiting ART clinic at Mizan Tep university Teaching Hospital (MTUTH), Southern Ethiopia from October 2017 to December 2017. Result: A total of 332 participants were enrolled in the study with the prevalence of alcohol use disorder (AUD) of 18.4%. Factors associated with alcohol use disorder were sex AOR=3.48 (95%CI: 1.27, 9.59), cigarette smoking AOR=5.12(95%CI:4.02,8.61), “Khat” chewing AOR=3.23(95%CI: 2.06,6.89),and CD4 count of 0-200 AOR = 19.49 (95% CI:1.74 ,218.4). Key words:-Magnitude, Alcohol use disorder, factors.


Sign in / Sign up

Export Citation Format

Share Document